Uncategorized – Clinical Trial Results

#ACC2025 Interventional Wrap Up:

April 18, 2025

Dr. Merhran and I discuss the HOST-BR trial (optimal DAPT duration for high or low bleeding risk), ECLIPSE trial (orbital […]

#SNACKABLEHEALTH with Gibson and Lam:

April 17, 2025

Dr. Lam and Dr. Gibson discuss the consistency of benefits with weight loss independent of GFR in the SUMMIT trial, […]

Dr. Sekar Kathiresan and Dr. C. Michael Gibson discuss “one and done” gene editing for high cholesterol by permanently inhibiting PCSK9 by about 70% to achieve an average LDL lowering of 59%.

April 14, 2025

Disclosures TBD

#ACC2025 Obesity Wrap Up:

April 14, 2025

Dr. Danielle Belardo and Dr. C. Michael Gibson discuss the PRAGUE-25 trial (catheter ablation vs. antiarrhythmics with weight management and […]

Dr. Joo- Yong Hahn and I discuss: Clopidogrel Versus Aspirin For Long-term Maintenance Monotherapy In Patients With High Ischemic Risk After Percutaneous Coronary Intervention

March 30, 2025

Disclosures: TBD

THIS WEEK IN NEPHROLOGY: Dr. Parikh and I discuss exciting new developments Xenotransplantation for patients with renal insufficiency.

February 26, 2025

Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson explore the question of what is the right weight reduction for each patient taking GLP-1 medications?

February 12, 2025

Disclosures: TBD

Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson discuss the SUMMIT trial and how GLP-1 agonists may be a new pillar in the treatment for HFpEF and obesity.

January 30, 2025

Disclosures: TBD

Drs. Wazni and Gibson do a deep dive on the results of the OPTION Trial answering many of the questions that have come up.

December 6, 2024

Dr. Thomas Crawford and Dr. C. Michael Gibson Discuss: Preliminary Results of Randomized Trial of New vs. Reconditioned Pacemakers for Patients Unable to Obtain a New Device in Low- and Middle-Income Countries: The My Heart Your Heart (MHYH) Randomized Trial

November 17, 2024

Disclosures: TBD